Qi Feng, Pinelopi Manousou, Chioma N. Izzi-Engbeaya, Mark Woodward
{"title":"根据新的SLD分类,两种ALD亚型的社会经济状况、临床特征和死亡率","authors":"Qi Feng, Pinelopi Manousou, Chioma N. Izzi-Engbeaya, Mark Woodward","doi":"10.1002/lci2.70019","DOIUrl":null,"url":null,"abstract":"<p>Under the new steatotic liver disease (SLD) framework, alcohol-related liver disease (ALD) is defined including two subtypes: (1) people with cardiometabolic risk factors (CMRFs) and with alcohol consumption > 50/60 g/day (for female/male), noted as ALD-1, and (2) people with daily alcohol consumption > 20/30 g/day but without CMRF, noted as ALD-2. However, little is known about the difference between these subtypes. Using UK biobank data, we identified individuals with ALD-1 and ALD-2 using the standard definition. We compared the two groups on their socioeconomic status, clinical characteristics, and mortality. Among 11 583 participants with ALD, only 17 (0.15%) had ALD-2. Compared to ALD-1, those with ALD-2 were more likely to be non-White, socioeconomically deprived, and smokers, with higher levels of ALT, AST, GGT, and FIB4 scores. The mortality rate was significantly higher in ALD-2 than ALD-1 (31.9 vs. 11.3 per 1000 person-years, HR 2.45 (95% CI 1.09, 5.50)). ALD-1 and ALD-2 exhibit substantial heterogeneity in socioeconomic status, lifestyle factors, clinical characteristics, and prognoses, suggesting distinct underlying mechanisms. These findings highlight the need for tailored management strategies that address the unique characteristics of each subtype.</p>","PeriodicalId":93331,"journal":{"name":"Liver cancer international","volume":"6 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lci2.70019","citationCount":"0","resultStr":"{\"title\":\"Socioeconomic Status, Clinical Characteristics and Mortality in Two Subtypes of ALD According to the New SLD Classifications\",\"authors\":\"Qi Feng, Pinelopi Manousou, Chioma N. Izzi-Engbeaya, Mark Woodward\",\"doi\":\"10.1002/lci2.70019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Under the new steatotic liver disease (SLD) framework, alcohol-related liver disease (ALD) is defined including two subtypes: (1) people with cardiometabolic risk factors (CMRFs) and with alcohol consumption > 50/60 g/day (for female/male), noted as ALD-1, and (2) people with daily alcohol consumption > 20/30 g/day but without CMRF, noted as ALD-2. However, little is known about the difference between these subtypes. Using UK biobank data, we identified individuals with ALD-1 and ALD-2 using the standard definition. We compared the two groups on their socioeconomic status, clinical characteristics, and mortality. Among 11 583 participants with ALD, only 17 (0.15%) had ALD-2. Compared to ALD-1, those with ALD-2 were more likely to be non-White, socioeconomically deprived, and smokers, with higher levels of ALT, AST, GGT, and FIB4 scores. The mortality rate was significantly higher in ALD-2 than ALD-1 (31.9 vs. 11.3 per 1000 person-years, HR 2.45 (95% CI 1.09, 5.50)). ALD-1 and ALD-2 exhibit substantial heterogeneity in socioeconomic status, lifestyle factors, clinical characteristics, and prognoses, suggesting distinct underlying mechanisms. These findings highlight the need for tailored management strategies that address the unique characteristics of each subtype.</p>\",\"PeriodicalId\":93331,\"journal\":{\"name\":\"Liver cancer international\",\"volume\":\"6 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lci2.70019\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Liver cancer international\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/lci2.70019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Liver cancer international","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/lci2.70019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在新的脂肪变性肝病(SLD)框架下,酒精相关性肝病(ALD)被定义为两种亚型:(1)有心脏代谢危险因素(CMRF)且每天饮酒50/60 g(女性/男性)的人,称为ALD-1;(2)每天饮酒20/30 g/天,但没有CMRF的人,称为ALD-2。然而,人们对这些亚型之间的差异知之甚少。使用英国生物银行的数据,我们使用标准定义识别出患有ALD-1和ALD-2的个体。我们比较了两组患者的社会经济地位、临床特征和死亡率。在11583名ALD患者中,只有17名(0.15%)患有ALD-2。与ALD-1相比,患有ALD-2的患者更可能是非白人、社会经济贫困和吸烟者,ALT、AST、GGT和FIB4评分水平较高。ALD-2组的死亡率明显高于ALD-1组(31.9 vs 11.3 / 1000人-年,HR 2.45 (95% CI 1.09, 5.50))。ALD-1和ALD-2在社会经济地位、生活方式因素、临床特征和预后方面表现出显著的异质性,表明其潜在机制不同。这些发现强调了针对每个亚型的独特特征制定量身定制的管理策略的必要性。
Socioeconomic Status, Clinical Characteristics and Mortality in Two Subtypes of ALD According to the New SLD Classifications
Under the new steatotic liver disease (SLD) framework, alcohol-related liver disease (ALD) is defined including two subtypes: (1) people with cardiometabolic risk factors (CMRFs) and with alcohol consumption > 50/60 g/day (for female/male), noted as ALD-1, and (2) people with daily alcohol consumption > 20/30 g/day but without CMRF, noted as ALD-2. However, little is known about the difference between these subtypes. Using UK biobank data, we identified individuals with ALD-1 and ALD-2 using the standard definition. We compared the two groups on their socioeconomic status, clinical characteristics, and mortality. Among 11 583 participants with ALD, only 17 (0.15%) had ALD-2. Compared to ALD-1, those with ALD-2 were more likely to be non-White, socioeconomically deprived, and smokers, with higher levels of ALT, AST, GGT, and FIB4 scores. The mortality rate was significantly higher in ALD-2 than ALD-1 (31.9 vs. 11.3 per 1000 person-years, HR 2.45 (95% CI 1.09, 5.50)). ALD-1 and ALD-2 exhibit substantial heterogeneity in socioeconomic status, lifestyle factors, clinical characteristics, and prognoses, suggesting distinct underlying mechanisms. These findings highlight the need for tailored management strategies that address the unique characteristics of each subtype.